Patent details
EP2648750 Title: ANTIBODY FORMULATION
Basic Information
- Publication number:
- EP2648750
- PCT Application Number:
- PCT/EP/2011/072248
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP118081785
- PCT Publication Number:
- WO/2012/076670
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- ANTIBODY FORMULATION
- French Title of Invention:
- FORMULATION D'ANTICORPS
- German Title of Invention:
- ANTIKÖRPER-FORMULIERUNG
- SPC Number:
Dates
- Filing date:
- 08/12/2011
- Grant date:
- 25/01/2017
- EP Publication Date:
- 25/01/2017
- PCT Publication Date:
- 14/06/2012
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 16/10/2013
- EP B1 Publication Date:
- 25/01/2017
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 08/12/2017
- Expiration date:
- 08/12/2031
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 08/12/2011
- Name:
- Novartis AG
- Address:
- Lichtstrasse 35, 4056 Basel, Switzerland (CH)
Inventor
1
- Name:
- HEUSSER Christoph
- Address:
- Switzerland (CH)
2
- Name:
- COSENZA Marta
- Address:
- Switzerland (CH)
3
- Name:
- WOISETSCHLAEGER Maximilian
- Address:
- Switzerland (CH)
4
- Name:
- SCHAADT Eveline
- Address:
- Germany (DE)
5
- Name:
- URLINGER Stefanie
- Address:
- Germany (DE)
6
- Name:
- NEUGEBAUER Julia
- Address:
- Germany (DE)
Priority
- Priority Number:
- 421650 P
- Priority Date:
- 10/12/2010
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- C07K 16/28;
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|